ANI Pharmaceuticals (ANIP) Earnings Date, Estimates & Call Transcripts $91.01 -0.13 (-0.14%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$91.15 +0.14 (+0.15%) As of 08/22/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANI Pharmaceuticals Earnings Summary ANI Pharmaceuticals released Q2 2025 earnings on August 8, 2025, reporting an EPS of $1.80, which beat the consensus estimate of $1.42 by $0.38. Quarterly revenue rose 53.2% year-over-year to $211.37 million, above the consensus estimate of $187.18 million. With a trailing EPS of -$0.77, ANI Pharmaceuticals' earnings are expected to grow 9.07% next year, from $3.86 to $4.21 per share. Latest Q2 Earnings DateAug. 8EstimatedConsensus EPS (Aug. 8) $1.42 Actual EPS (Aug. 8) $1.80 Beat By $0.38 Actual Revenue (Aug. 8) $211.37MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingPowered by Get ANI Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ANI Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataANIP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ANI Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$0.91$1.13$1.02Q2 20252$1.02$1.27$1.15Q3 20252$1.13$1.23$1.18Q4 20252$1.40$1.50$1.45 ANI Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025$1.42$1.80+$0.38$0.36$187.18M$211.37M5/9/2025Q1 2025$1.37$1.70+$0.33$0.69$179.75M$197.12M11/8/2024Q3 2024$1.09$1.34+$0.25$3.35$144.37M$148.30M8/6/2024Q2 2024$0.95$1.02+$0.07$1.58$129.09M$138.00M5/10/2024Q1 2024$0.79$0.95+$0.16$1.08$125.01M$137.43M2/29/2024Q4 2023$0.58$0.78+$0.20$1.52$123.02M$131.65M11/8/2023Q3 2023$0.84$1.27+$0.43$1.65$111.92M$131.83M ANI Pharmaceuticals Earnings - Frequently Asked Questions When did ANI Pharmaceuticals announce their last quarterly earnings? ANI Pharmaceuticals (NASDAQ:ANIP) last announced its quarterly earning data on Friday, August 8, 2025. Learn more on ANIP's earnings history. What guidance has ANI Pharmaceuticals issued on next quarter's earnings? ANI Pharmaceuticals issued an update on its FY 2025 earnings guidance on Sunday, August, 17th. The company provided earnings per share (EPS) guidance of 6.980-7.350 for the period, compared to the consensus estimate of 6.523. The company issued revenue guidance of $818.0 million-$843.0 million, compared to the consensus revenue estimate of $788.1 million. Did ANI Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ANI Pharmaceuticals (NASDAQ:ANIP) reported $1.80 earnings per share (EPS) to beat the analysts' consensus estimate of $1.42 by $0.38. Learn more on analysts' earnings estimate vs. ANIP's actual earnings. How can I listen to ANI Pharmaceuticals' earnings conference call? The conference call for ANI Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read ANI Pharmaceuticals' conference call transcript? The conference call transcript for ANI Pharmaceuticals' latest earnings report can be read online. Read Transcript How can I view ANI Pharmaceuticals' earnings report? ANI Pharmaceuticals' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded annual revenue of $614.38 million. How much profit does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded net income of -$18.52 million. ANIP has generated -$0.77 earnings per share over the last four quarters. What is ANI Pharmaceuticals' EPS forecast for next year? ANI Pharmaceuticals' earnings are expected to grow from $3.86 per share to $4.21 per share in the next year, which is a 9.07% increase. More Earnings Resources from MarketBeat Related Companies ADMA Biologics Earnings Date Annovis Bio Earnings Date Legend Biotech Earnings Date Revolution Medicines Earnings Date Rhythm Pharmaceuticals Earnings Date Avidity Biosciences Earnings Date Nuvalent Earnings Date Axsome Therapeutics Earnings Date CRISPR Therapeutics Earnings Date Merus Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:ANIP) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredThe New Way Retirees Are Getting Paid Extra Every MonthBloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access